S. 2294: Kay Hagan Tick Reauthorization Act

This bill, titled the Kay Hagan Tick Reauthorization Act, aims to extend funding and support for programs that deal with tick-borne diseases and related concerns. Here are the key components of the legislation:

1. Program Reauthorization

The bill proposes to reauthorize certain programs focused on managing and combating vector-borne diseases (diseases transmitted by vectors such as ticks). Specifically, it addresses the following:

• Adjustments in Oversight: The bill modifies language concerning who is involved in the strategic planning for these diseases. It removes specific references to a working group established by a previous act and instead allows for the inclusion of appropriate individuals in this planning.
• Funding Adjustments: The legislation changes the funding allocations for tick-related initiatives:
  • The initial program funding will be reduced from $10 million annually (for fiscal years 2021-2025) to $8 million annually for the fiscal years 2026-2030.
  • Similarly, funding for assisting health departments to combat vector-borne diseases will be decreased from $20 million annually (for fiscal years 2021-2025) to $19 million annually for the fiscal years 2026-2030.

2. Focus on Vector-Borne Diseases

The reauthorization of these programs is aimed at enhancing the support provided to health departments across the nation to address vector-borne diseases, emphasizing the need to adapt to changing public health needs and circumstances.

3. Timeframe and Future Implications

This bill will set a new timeline for the implementation of its provisions, extending support and funding for tick-related health initiatives through the year 2030, while also providing a framework for ongoing adjustments to address these public health challenges.

Relevant Companies

• None found